Skip to main content
main-content

05.06.2018 | Bone Marrow and Adipose Tissue (G Duque and B Lecka-Czernik, Section Editors) | Ausgabe 4/2018

Current Osteoporosis Reports 4/2018

The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone

Zeitschrift:
Current Osteoporosis Reports > Ausgabe 4/2018
Autoren:
Jonathan D. Diedrich, Mackenzie K. Herroon, Erandi Rajagurubandara, Izabela Podgorski
Wichtige Hinweise
This article is part of the Topical Collection on Bone Marrow and Adipose Tissue

Abstract

Purpose of Review

Bone marrow adipocytes have emerged in recent years as key contributors to metastatic progression in bone. In this review, we focus specifically on their role as the suppliers of lipids and discuss pro-survival pathways that are closely linked to lipid metabolism, affected by the adipocyte-tumor cell interactions, and likely impacting the ability of the tumor cell to thrive in bone marrow space and evade therapy.

Recent Findings

The combined in silico, pre-clinical, and clinical evidence shows that in adipocyte-rich tissues such as bone marrow, tumor cells rely on exogenous lipids for regulation of cellular energetics and adaptation to harsh metabolic conditions of the metastatic niche. Adipocyte-supplied lipids have a potential to alter the cell’s metabolic decisions by regulating glycolysis and respiration, fatty acid oxidation, lipid desaturation, and PPAR signaling. The downstream effects of lipid signaling on mitochondrial homeostasis ultimately control life vs. death decisions, providing a mechanism for gaining survival advantage and reduced sensitivity to treatment.

Summary

There is a need for future research directed towards identifying the key metabolic and signaling pathways that regulate tumor dependence on exogenous lipids and consequently drive the pro-survival behavior in the bone marrow niche.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Bis zum 22.10. bestellen und 100 € sparen!

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2018

Current Osteoporosis Reports 4/2018 Zur Ausgabe

Rare Bone Disease (C Langman and E Shore, Section Editors)

Modeling Rare Bone Diseases in Animals

Orthopedic Management of Fractures (S Bukata and L Gerstenfeld, Section Editors)

Origin of Reparative Stem Cells in Fracture Healing

Muscle and Bone (L Bonewald and M Hamrick, Section Editors)

Osteogenesis Imperfecta: Muscle–Bone Interactions when Bi-directionally Compromised

Orthopedic Management of Fractures (S Bukata and L Gerstenfeld, Section Editors)

Recent Advances and Future of Gene Therapy for Bone Regeneration

Cancer-induced Musculoskeletal Diseases (J Sterling and E Keller, Section Editors)

Surgical Approach to Bone Metastases

Neu im Fachgebiet Orthopädie und Unfallchirurgie

 

 

 
 

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Orthopädie und Unfallchirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise